Relay Therapeutics, Inc.

NASDAQ:RLAY

3 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -337.708-341.973-290.509-363.872-52.412-75.305-48.785
Depreciation & Amortization -6.8515.2694.133.9253.5492.8452.154
Deferred Income Tax 0002.052000
Stock Based Compensation 94.13986.03156.13848.45431.964.4562.887
Change In Working Capital 0-32.45811.24697.344-85.174.31-0.4
Accounts Receivables 05.2190.09774.677-7500
Inventory 00021.46-10.33100
Accounts Payables 10.268-2.3941.9890.93-0.4131.232
Other Working Capital 4.352-35.2839.160.2770.5711.31-1.632
Other Non Cash Items 1.313-17.185-10.495137.691-0.416-2.4390.009
Operating Cash Flow -249.107-300.316-229.49-74.406-102.489-66.133-44.135
Investing Activities:
Investments In Property Plant And Equipment -2.018-4.126-9.062-3.471-1.931-8.002-1.687
Acquisitions Net 00179.683-25.298-83.6030.020.007
Purchases Of Investments -650.629-385.542-535.419-980.665-266.455-553.5170
Sales Maturities Of Investments 611.463647.302355.736529.923350.058242.4750
Other Investing Activites 0.1010-179.683-450.74283.603-311.0220.007
Investing Cash Flow -41.083257.634-188.745-479.51181.672-319.024-1.68
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 265.89230.281284.744382.21425.2930.6130.799
Common Stock Repurchased 1.47900000-0.082
Dividends Paid 0000000
Other Financing Activities 4.2614.4725.1665.881.2165.606394.972
Financing Cash Flow 270.15334.753289.91388.09426.5095.606394.972
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -20.037-7.929-128.325-165.827405.692-379.551349.157
Cash At End Of Period 126.406146.443154.372282.697448.52442.832422.383